About Us

Why Alkemi

Alkemi establishes patient access in a rapidly evolving, evidence-based, and value-conscious health policy environment. Our projects deliver strategic and tactical plans and often include design and execution of evidence studies, development and training on communication tools and participation or leadership of negotiations with regulator, payer, and institutional decision-makers to enable patient access.

Our Expertise

Decades of senior-level industry experience in medical and commercial roles

Strong methodological backgrounds across clinical, pharmacy and outcomes research

Experience negotiating novel payment and access arrangements across markets

Practical application of market access and evidence strategies

Our Values

Advance Health Outcomes

We effectively pursue the strategic goals of our clients toward achieving better health outcomes. We provide excellence in life sciences consulting to healthcare stakeholders to improve the quality of care and patient, provider, and payer outcomes.


We do what is right for our clients, our employees, and the global healthcare community. In the pursuit of client goals, we relentlessly seek solutions that advance meaningful outcomes for providers, payers, public policy, and patient stakeholders through evidence-based research.

Deliver Value

At all times, we pursue the strategic goals of our clients toward achieving better health outcomes.

Meet our Team

Betsy Lahue, CEO, brings over two decades of experience as a former health economics, outcomes research and market access healthcare executive. Ms. Lahue served on both Commercial and R&D leadership teams and regularly presented to the Board of Directors of a Fortune 500 healthcare company. Her experiences span all sectors of life science technology including pharma/biotech, medical device, and diagnostics. In rare diseases, Ms. Lahue had an opportunity to broker novel funding and access arrangements with national and regional authorities. As CEO of Alkemi, she provides strategic guidance to clients on product value assessments, evidence plans, regulatory endpoints and payer/HTA strategies to ensure patient access at the value-based price. Ms. Lahue earned a BA in Chemistry and English from Amherst College and her MPH from the Boston University School of Public Health. She currently serves on the Board of Directors for EvoEndo.

Betsy J. Lahue, MPH


Drives vision, strategy, and execution
Robert Lahue, Chief Operating Officer, drives company growth and ensures financial efficiency in the pursuit of our mission. His business development and talent recruiting acumen spans healthcare, commercial real estate, and mixed investment portfolios. With over 20 years of financial management and strategic investment experience, he has successfully built and sold two businesses. Prior roles in industry include Regional Marketing Director and Sales Leader. Mr. Lahue earned a BS from Babson College.

Robert H. Lahue


Manages business operations and client development
Dr. Kristen Cribbs, Senior Research Director, leads policy, programmatic, and research ranging from study design and instrument development to quantitative and qualitative data collection and data analysis. The Alkemi research team under Dr. Cribbs’ supervision develops value messages, creates payer communication tools, and conducts systematic literature reviews, meta-analyses, and health economic modeling. Dr. Cribbs earned a PhD in Health Policy and Management from CUNY Graduate School of Public Health and Health Policy; an MPH in Sociomedical Sciences from Columbia University’s Mailman School of Public Health; and an AB in Psychology from Occidental College.

Kristen Cribbs, PhD, MPH

Senior Research Director

Oversees research operations and ensures excellence in all deliverables
Wesley Baisley, Research Associate, specializes in development of data analysis and research strategies. Recent projects include targeted literature reviews, data on file analyses, poster design and development and execution of statistical analysis plans. Mr. Baisley’s prior research background includes the study of neurobiology of emotion, biochemical substrates of hearing, and evaluating REM sleep in mice via optogenetic experimentation. Mr. Baisley is a four-year veteran of the military and earned a BS in Neuroscience and Behavior from Columbia University.

Wesley Baisley

Research Associate

Conducts data analysis and outcomes research
Gio Shoushi, Research Analyst, synthesizes market access insights. Mr. Shoushi previously led primary and secondary research on oncology market trends. His experiences included identifying thought-leader preferences and conducting an opportunity assessment for novel therapies and diagnostic technologies. Mr. Shoushi earned a BS in Biochemistry-Molecular Biology from UC Santa Barbara and a Masters in Business and Science from Keck Graduate Institute.

Gio Shoushi, MS

Research Analyst

Analyzes health outcomes and synthesizes insights
Lailoo Perriello, Research Analyst, specializes in literature analysis and development of research strategies. Ms. Perriello previously led market and consumer trend research on pharmaceutical drugs and has spearheaded recruitment and summary reporting of clinical research subjects at Massachusetts General Hospital. Her experiences included discrete customer segmentation, survey development, and response theme analysis. Ms. Perriello earned a BA in Biology and Sociology from Bowdoin College.

Lailoo Perriello

Research Analyst

Develops research strategies, analyzes literature
Lucas Blackmore, HEOR Fellow, synthesizes evidence, reviews guidelines and conducts data analyses related to disease burden, healthcare interventions, patient outcomes, and healthcare economics. He conducts evaluations of pharmaceutical and medical technologies to develop evidence-based dossiers for payers and other market access decision-makers in key global markets. Mr. Blackmore’s previous research involved using innovative health technology tools for infectious disease surveillance and response strategies in low- and middle-income countries. Mr. Blackmore earned a BS in Biopsychology from Queen’s University and a Masters in Public Health from Brown University.

Lucas Blackmore, MPH

HEOR Fellow

Synthesizes evidence and conducts data analysis
Alkemi Icon

Our History

Alkemi formed to provide Evidence and Access Support to innovative medical partners


Engaged on five rare disease assets across two fortune 500 companies


Evidence Communications: Payer dossiers and medical training decks


Landscape Monitoring: Evidence insights


Evidence Design and Analytical Support: Data Analysis


HEOR Partner: Operational Support


Global Expert Network: HEOR and Market Access Analysis


Celebrating 5 years of excellence in Health Economics and Outcomes Research, and Market Access Consulting!


Recognized by Inc. Magazine 2023: Fastest-Growing Companies at #37 in the Northeast United States


Alkemi Ranks No. 395 on the Inc. 5000 - Among America's Fastest-Growing Private Companies

Our Vision Statement
“Alkemi advances public health and improves outcomes by increasing access to medical innovation.”

We are driven by our vision of advancing public health, delivering value in healthcare, and improving patient outcomes. Utilizing our healthcare experience and global payer expertise, we provide clients with strategic tools and resources required to bring medical innovation to patients. Our creativity and novel value demonstration approaches meet requirements for commercial enterprises, healthcare providers, and payers. In doing so, we ensure that patients have rapid access to the most effective and efficient treatments available.